Should You Accumulate Neurobo Pharmaceuticals Inc (NRBO) Stock Wednesday Morning?

Neurobo Pharmaceuticals Inc (NRBO) is down Wednesday morning, with the stock losing -13.60% in pre-market trading to 3.43. NRBO's short-term technical score of 12 indicates that the stock has traded less bullishly over the last month than 88% of stocks on the market. In the Biotechnology industry, which ranks 140 out of 146 industries, Neurobo Pharmaceuticals Inc ranks higher than 29% of stocks. Neurobo Pharmaceuticals Inc has risen 21.41% over the past month, closing at $3.21 on June 23. During this period of time, the stock fell as low as $2.73 and as high as $3.46. NRBO has an average analyst recommendation of Strong Buy. The company has an average price target of $16.00.

NRBO has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on NRBO!

See Full NRBO Report

Neurobo Pharmaceuticals Inc has a Long-Term Technical rank of 33. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 67% of the market scoring higher. In the Biotechnology industry which is number 138 by this metric, NRBO ranks better than 68% of stocks.

Important Dates for Investors in NRBO:

-Neurobo Pharmaceuticals Inc is set to release earnings on 8/10/2021. During their last earnings release the company posted EPS of $-1.69. -We do not have a set dividend date for Neurobo Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Neurobo Pharmaceuticals Inc (NRBO)